<table id="table4" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 4: Population Pharmacokinetic Estimates of Etravirine 200 mg twice daily in HIV-1-Infected Adult Subjects (Integrated Data from Phase 3 Trials at Week 48)<linkhtml href="#footnote-1">*</linkhtml>
</caption>
<col align="left" span="1" valign="top" width="50%"></col>
<col align="center" span="1" valign="top" width="50%"></col>
<tbody>
<tr>
<th colspan="1">Parameter</th>
<th colspan="1">Etravirine 200 mg twice daily<br/>N = 575</th>
</tr>
<tr>
<td>AUC<sub>12h</sub> (ng∙h/mL)</td>
<td></td>
</tr>
<tr>
<td>  Geometric Mean ± Standard Deviation</td>
<td>4522 ± 4710</td>
</tr>
<tr>
<td>  Median (Range)</td>
<td>4380 (458 – 59084)</td>
</tr>
<tr>
<td>C<sub>0h</sub> (ng/mL)</td>
<td></td>
</tr>
<tr>
<td>  Geometric Mean ± Standard Deviation</td>
<td>297 ± 391</td>
</tr>
<tr>
<td>  Median (Range)</td>
<td>298 (2 – 4852)</td>
</tr>
</tbody>
</table>